Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | ATM | Q13315 | 3/20 | 0.61 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.61 |
| ▸ | PRNP | P04156 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.51 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.51 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.51 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.51 |
| ▸ | CSF1R | P07333 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29407052 | 0.88 | ALDH1A1 (0.57) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL29406607 | 0.88 | ALDH1A1 (0.57) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL12317104 | 0.87 | ALDH1A1 (0.56) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL650086 | 0.83 | L3MBTL1 (0.64) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL30476324 | 0.83 | L3MBTL1 (0.64) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL21281903 | 0.82 | L3MBTL1 (0.53) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL1301829 | 0.81 | ALDH1A1 (0.68) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL28478677 | 0.81 | KDM4E (0.57) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL31070203 | 0.81 | MAPK14 (0.51) | KMT2AKDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL18647352 | 0.81 | PRNP (0.62) | KMT2AALDH1A1L3MBTL1ATMPRNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192275-A | Cyclobutadiene-containing luminescent material, preparation method and application | 深圳大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-118420551-A | Method for synthesizing quinoxaline compound by catalytic synthesis of cyclopentadienyl titanium complex | 宁夏师范学院 | 2024-08-02 | — | — | CN | disclosed |
| CN-114380803-B | Spirobifluorene compound, electron transport composition, and organic electroluminescent device | 常州强力电子新材料股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| WO-2023160187-A1 | CARBAZOLE DERIVATIVE AND USE THEREOF | 上海八亿时空先进材料有限公司 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023138254-A1 | HETEROCYCLIC COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL AND ELEMENT | 上海八亿时空先进材料有限公司 | 2023-07-27 | — | — | WO | disclosed |
| CN-116217557-A | Dibenzofuran-containing compound and organic electroluminescent element | 常州强力昱镭光电材料有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-114380803-A | Spirobifluorene compound, electron transport composition and organic electroluminescent device | 常州强力昱镭光电材料有限公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-111116496-B | Synthetic method of quinoxaline heterocyclic derivative | 扬州大学 | 2021-12-31 | — | — | CN | disclosed |
| CN-111187225-B | Condensed ring aromatic hydrocarbon derivative with quinoxaline group and application thereof | 北京鼎材科技有限公司 | 2021-06-11 | — | — | CN | disclosed |
| CN-110386925-B | Bipolar molecule derivative for organic light-emitting element | 祥德科技股份有限公司 | 2021-04-02 | — | — | CN | disclosed |
| US-9353065-B2 | Heterocyclic bridged biphenyls | BASF SE (DE) | 2016-05-31 | — | — | US | disclosed |
| US-9353065-B2 | Heterocyclic bridged biphenyls | BASF SE (DE) | 2016-05-31 | — | — | US | disclosed |
| EP-2125752-B1 | HETEROCYCLIC BRIDGED BIPHENYLS | BASF SE (DE) | 2015-08-12 | — | — | EP | disclosed |
| EP-2125752-B1 | HETEROCYCLIC BRIDGED BIPHENYLS | BASF SE (DE) | 2015-08-12 | — | — | EP | disclosed |
| US-20100109514-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| US-20100109514-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| US-20100109514-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| EP-2125752-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | BASF SE (DE) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008119666-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | BASF SE (CH) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008119666-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | BASF SE (CH) | 2008-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100109514-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | OCIAD1, SBDS, OCIAD2 | KMT2A 3605/4885KDM4E 3206/4885ALDH1A1 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.